Granulomatous Diseases of the Liver

Zakim and Boyer's Hepatology

Volumn , Issue , 2006, Pages 767-780

  Sharma, Shobha ^a  

^a EMORY UNIVERSITY HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84882870385     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-1-4160-3258-8.50043-7     Document Type: Chapter

References (190)

1. Klatskin G. Hepatic granulomata. Problems in interpretation. Mt Sinai J Med 1977, 44:798-812.
2. Denk H, Scheuer PJ, Baptista A, et al. Guidelines for the diagnosis and interpretation of hepatic granulomas. Histopathology 1994, 25:209-218.
3. Lucey DR, Clerici M, Shearer GM Type 1 and type 2 cytokine disregulation in human infectious, neoplastic, and inflammatory diseases. Clin Microbiol Rev 1996, 9:532-562.
4. Baumer I, Zissel G, Schlaak M, et al. Th1/Th2 cell distribution in pulmonary sarcoidosis. Am J Respir Cell Mol Biol 1997, 16:171-177.
5. Agostini C, Basso U, Semenzato G. Cells and molecules involved in the development of sarcoid granuloma. J Clin Immunol 1998, 18:184-192.
6. Infante-Duarte C, Kamradt T. Th1/Th2 balance in infection. Springer Semin Immunopathol 1999, 21:317-338.
7. Mitchison NA, Schuhbauer D, Muller B Natural and induced regulation of Th1/Th2 balance. Springer Semin Immunopathol 1999, 21:199-210.
8. Chensue SW, Ruth JH, Warmington K, et al. In vivo regulation of macrophage IL-12 production during type 1 and type 2 cytokine-mediated granuloma formation. J Immunol 1995, 155:3546-3551.
9. Chensue SW, Warmington K, Ruth J, et al. Cytokine responses during mycobacterial and schistosomal antigen-induced pulmonary granuloma formation. Production of Th1 and Th2 cytokines and relative contribution of tumor necrosis factor. Am J Pathol 1994, 145:1105-1113.
10. Wynn TA, Cheever AW Cytokine regulation of granuloma formation in schistosomiasis. Curr Opin Immunol 1995, 7:505-511.
11. Chensue SW, Warmington KS, Hershey SD, et al. Evolving T cell responses in murine schistosomiasis. Th2 cells mediate secondary granulomatous hypersensitivity and are regulated by CD8+ T cells in vivo. J Immunol 1993, 151:1391-1400.
12. Chensue SW, Warmington K, Ruth JH, et al. Effect of slow release IL-12 and IL-10 on inflammation, local macrophage function and the regional lymphoid response during mycobacterial (Th1) and schistosomal (Th2) antigen-elicited pulmonary granuloma formation. Inflamm Res 1997, 46:86-92.
13. Amiri P, Locksley RM, Parslow TG, et al. Tumor necrosis factor α restores granulomas and induces parasite egg-laying in schistosome-infected SCID mice. Nature 1992, 356:604-607.
14. Molos MA, Litton N, Schubert TT Talc liver. J Clin Gastroenterol 1987, 9:198-203.
15. Allaire GS, Goodman ZD, Ishak KG, et al. Talc in liver tissue of intravenous drug abusers with chronic hepatitis. A comparative study. Am J Clin Pathol 1989, 92:583-588.
16. Mitchell DP, Hanes TE, Hoyumpa AM, et al. Fever of unknown origin. Assessment of the value of percutaneous liver biopsy. Arch Intern Med 1977, 137:1001-1004.
17. Masana L, Guardia J, Clotet B, et al. Liver biopsy in fever of unknown origin. Gastroenterol Clin Biol 1980, 4:215-218.
18. Holtz T, Moseley RH, Scheiman JM Liver biopsy in fever of unknown origin. A reappraisal. J Clin Gastroenterol 1993, 17:29-32.
19. Guckian JC, Perry JE Granulomatous hepatitis. An analysis of 63 cases and review of the literature. Ann Intern Med 1966, 65:1081-1100.
20. Abdi WA, Millan JC, Mezey E Sampling variability on percutaneous liver biopsy. Arch Intern Med 1979, 139:667-669.
21. Maharaj B, Maharaj RJ, Leary WP, et al. Sampling variability and its influence on the diagnostic yield of percutaneous needle biopsy of the liver. Lancet 1986, 8480:523-525.
22. Dincsoy HP, Weesner RE, MacGee J Lipogranulomas in non-fatty human livers. A mineral oil induced environmental disease. Am J Clin Pathol 1982, 78:35-41.
23. Wagoner GP, Anton AT, Gall EA, et al. Needle biopsy of the liver. VIII. Experiences with hepatic granulomas. Gastroenterology 1953, 25:487-494.
24. Iversen K, Christoffersen P, Poulsen H. Epithelioid cell granulomas in liver biopsies. Scand J Gastroenterol 1970, 7(Suppl):61-67.
25. Mir-Madjilessi SH, Farmer RG, Hawk WA Spectrum of hepatic manifestations of granulomatous hepatitis of unknown etiology. Am J Gastroenterol 1974, 62:221-229.
26. Irani SK, Dobbins WO Hepatic granulomas: A review of 73 patients from one hospital and a survey of the literature. J Clin Gastroenterol 1979, 1:131-143.
27. Anderson CS, Nicholls N, Rowland R, et al. Hepatic granulomas: a 15-year experience in the Royal Adelaide Hospital. Med J Aust 1988, 148:71-74.
28. Satti MB, Al-Freihi H, Ibrahim EM, et al. Hepatic granuloma in Saudia Arabia: A clinicopathological study of 59 cases. Am J Gastroenterol 1990, 85:669-674.
29. McCluggage WG, Sloan JM Hepatic granulomas in Northern Ireland: a thirteen year review. Histopathology 1994, 25:219-228.
30. Sabharwal BD, Malhotra N, Garg R, et al. Granulomatous hepatitis: a retrospective study. Indian J Pathol Microbiol 1995, 38:413-416.
31. Barcena R, Sanroman AL, Del Campo S, et al. Posttransplant liver granulomatosis associated with hepatitis C?. Transplantation 1998, 65:494-1495.
32. Yamamoto S, Iguchi Y, Ohomoto K, et al. Epithelioid granuloma formation in type C chronic hepatitis: report of two cases. Hepatogastroenterology 1995, 42:291-293.
33. Emile JF, Sebagh M, Feray C, et al. The presence of epithelioid granulomas in hepatitis C virus related cirrhosis. Hum Pathol 1993, 24:1095-1097.
34. Goldin RD, Levine TS, Foster GR, Thomas HC Granulomas and hepatitis C. Histopathology 1996, 28:265-267.
35. Propst A, Propst T, Dietz O, et al. Development of granulomatous hepatitis during treatment with interferonα2b. [Letter] Dig Dis Sci 1995, 40:2117-2118.
36. Veerabagu MP, Finkelstein SD, Rabinovitz M Granulomatous hepatitis in a patient with chronic hepatitis C treated with interferonα. Dig Dis Sci 1997, 42:1445-1448.
37. Bonnet F, Morlat P, Dubuc S, et al. Sarcoidosis-associated hepatitis C virus infection. Dig Dis Sci 2002, 47:794-796.
38. Hoffman RM, Jung M-C, Motz R, et al. Sarcoidosis associated with interferonα therapy for chronic hepatitis C. J Hepatol 1998, 28:1058-1063.
39. Kaplan MM Primary biliary cirrhosis. N Engl J Med 1996, 335:1570-1580.
40. Portmann BC, MacSween RNM Diseases of the intrahepatic bile ducts. Pathology of the liver 1994, 477. Churchill Livingstone, Edinburgh. 3rd edn. R.N.M. MacSween, P.P. Antony, P.J. Scheuer (Eds.).
41. Comer GM, Mukherjee S, Scholes JV, et al. Liver biopsies in the acquired immune deficiency syndrome: influence of endemic disease and drug abuse. Am J Gastroenterol 1989, 84:1525-1531.
42. Prego V, Glatt AE, Roy V, et al. Comparative yield of blood culture for fungi and mycobacteria, liver biopsy, and bone marrow biopsy in the diagnosis of fevers of undetermined origin in human immunodeficiency virus-infected patients. Arch Intern Med 1990, 150:333-336.
43. Bach N, Theise ND, Schaffner F Hepatic histopathology in the acquired immunodeficiency syndrome. Semin Liver Dis 1992, 12:205-212.
44. Wilkins MJ, Lindley R, Dourakis SP, et al. Surgical pathology of the liver in HIV infection. Histopathology 1991, 18:459-464.
45. Orenstein MS, Tavitian A, Yonk B, et al. Granulomatous involvement of the liver in patients with AIDS. Gut 1985, 26:1220-1225.
46. Lebovics E, Thung SN, Schaffner F, et al. The liver in the acquired immunodeficiency syndrome: a clinical and histologic study. Hepatology 1985, 5:293-298.
47. Cucin RL, Coleman M, Eckardt JJ, et al. The diagnosis of miliary tuberculosis: utility of peripheral blood abnormalities, bone marrow and liver needle biopsy. J Chronic Dis 1973, 26:355-361.
48. Parkes SA, Baker SB, de C, Bourdillon RE, et al. Incidence of sarcoidosis in the Isle of Man. Thorax 1985, 40:284-287.
49. Parkes SA, Baker SB, de C, Bourdillon RE, et al. Epidemiology of sarcoidosis in the Isle of Man - 1: A case-controlled study. Thorax 1987, 42:420-426.
50. Hills SE, Parkes SA, Baker SB de C. Epidemiology of sarcoidosis in the Isle of Man - 2: Evidence for space time clustering. Thorax 1987, 42:427-430.
51. Mandel J, Weinberger SE Clinical insights and basic science correlates in sarcoidosis. Am J Med Sci 2001, 1:99-107.
52. Newman LS, Rose CS, Maier LA Sarcoidosis. N Engl J Med 1997, 336:1224-1234.
53. Statement on Sarcoidosis. The joint statement of the American Thoracic Society (ATS), the European Respiratory Society (ERS) and the World Association of Sarcoidosis and other granulomatous disorders (WASOG). Am J Respir Crit Care Med 1999, 160:736-755.
54. Maddrey WC, Johns CJ, Boitnott JK, et al. Sarcoidosis and chronic hepatic disease: a clinical and pathologic study of 20 patients. Medicine 1970, 49:375-395.
55. Rudzki C, Ishak KG, Zimmerman HJ Chronic intrahepatic cholestasis of sarcoidosis. Am J Med 1975, 59:373-387.
56. Nakanuma Y, Ohta G, Yamazaki Y, et al. Intrahepatic bile duct destruction in a patient with sarcoidosis and chronic intrahepatic cholestasis. Acta Pathol Jpn 1979, 29:211-219.
57. Lehmuskallio E, Hannuksela M, Halme H. The liver in sarcoidosis. Acta Med Scand 1977, 202:289-293.
58. Valla D, Pessegueiro-Miranda H, Degott C, et al. Hepatic sarcoidosis with portal hypertension. A report of seven cases with a review of the literature. Q J Med 1987, 63:531-544.
59. Ishak KG Sarcoidosis of the liver and bile ducts. Mayo Clin Proc 1998, 73:467-472.
60. Hercules HC, Bethlem NM Value of liver biopsy in sarcoidosis. Arch Pathol Lab Med 1984, 108:831-834.
61. Rasmussen SM, Neukirch F Sarcoidosis. A clinical study with special reference to the choice of biopsy procedure. Acta Med Scand 1976, 199:209-216.
62. Devaney K, Goodman ZC, Epstein MS, et al. Hepatic sarcoidosis. Clinicopathologic features in 100 patients. Am J Surg Pathol 1993, 17:1272-1280.
63. Tekeste H, Latour F, Levitt RE Portal hypertension complicating sarcoid liver disease: case report and review of the literature. Am J Gastroenterol 1984, 79:389-396.
64. Moreno-Merlo F, Wanless IR, Shimamatsu K, et al. The role of granulomatous phlebitis and thrombosis in the pathogenesis of cirrhosis and portal hypertension in sarcoidosis. Hepatology 1997, 26:554-560.
65. Nakanuma Y, Kouda W, Harada K, et al. Hepatic sarcoidosis with vanishing bile duct syndrome, cirrhosis, and portal phlebosclerosis. Report of an autopsy case. J Clin Gastroenterol 2001, 32:181-184.
66. Alam I, Levenson SD, Ferrell LD, et al. Diffuse intrahepatic biliary strictures in sarcoidosis resembling sclerosing cholangitis. Case report and review of the literature. Dig Dis Sci 1997, 42:1295-1301.
67. Israel HL, Goldstein RA Hepatic granulomatosis and sarcoidosis. Ann Intern Med 1973, 79:669-678.
68. Murphy JR, Sjogren MH, Kikendall JW, et al. Small bile duct abnormalities in sarcoidosis. J Clin Gastroenterol 1990, 12:555-561.
69. Becheur H, Dall'Osto H, Chatellier G, et al. Effect of ursodeoxhycholic acid on chronic intrahepatic cholestasis due to sarcoidosis. Dig Dis Sci 1997, 42:789-791.
70. Baratta L, Cascino A, Delfino M, et al. Ursodeoxycholic acid treatment in abdominal sarcoidosis. Dig Dis Sci 2000, 45:1559-1562.
71. Casavilla FA, Gordon R, Wright HI, et al. Clinical course after liver transplantation in patients with sarcoidosis. Ann Intern Med 1993, 118:865-866.
72. Fidler HM, Hadziyannis SJ, Dhillon AP, et al. Recurrent hepatic sarcoidosis following liver transplantation. Transplant Proc 1997, 29:2509-2510.
73. Hunt J, Gordon FD, Jenkins RL, et al. Sarcoidosis with selective involvement of a second liver allograft: report of a case and review of the literature. Mod Pathol 1999, 12:325-328.
74. Wiest PM, Olds GR Clinical schistosomiasis. R I Med J 1992, 75:179-185.
75. The control of schistosomiasis. WHO Technical Report Series 1993, 830:1-87. National Institutes of Health Consensus Development Conference Statement.
76. Elliot DE Schistosomiasis. Pathophysiology, diagnosis and treatment. (Review). Gastroenterol Clin North Am 1996, 25:599-625.
77. Bica I, Hamer DH, Stadecker MJ Hepatic schistosomiasis. Infect Dis Clin North Am 2000, 3:583-604.
78. McKerrow JH Cytokine induction and exploitation in Schistosome infections. Parasitology 1997, 115:S107-S112.
79. Boros DL T helper cell populations, cytokine dynamics, and pathology of the schistosome egg granuloma. Microbes Infect 1999, 1:511-516.
80. Stadecker MJ The development of granulomas in schistosomiasis: genetic backgrounds, regulatory pathways, and specific egg antigen responses that influence the magnitude of disease. Microbes Infect 1999, 1:505-510.
81. Cheever AW, Andrade ZA Pathological lesions associated with Schistosoma mansoni infection in man. Trans Roy Soc Trop Med Hyg 1967, 61:626-639.
82. Edington GM, Lichtenberg F, von Nwabuebo I, et al. Pathologic effects of schistosomiasis in Ibadan, Western State of Nigeria. I. Incidence and intensity of infection; distribution and severity of lesions. Am J Trop Med Hyg 1970, 19:982-995.
83. Cheever AW Pipe-stem fibrosis of the liver. Trans Roy Soc Trop Med Hyg 1972, 66:947-948.
84. Bhagwandeen SB Bilharzial pipe-stem portal fibrosis in Zambia. J Pathol 1973, 111:23-30.
85. Marquet S, Abel L, Hillaire D, et al. Genetic localization of a locus controlling the intensity of infection by Schistosoma mansoni on chromosome 5q31-q33. Nature Genet 1996, 14:181-184.
86. Dessein AJ, Hillaire D, Eldin N, et al. Severe hepatic fibrosis in Schistosoma mansoni infection is controlled by a major locus that is closely linked to the interferonγ receptor gene. Am J Hum Genet 1999, 65:709-721.
87. Chevillard C, Moukoko CE, Elwali N-EMA, et al. INFγ polymorphisms (INFγ +2109 and INFγ +3810) are associated with severe hepatic fibrosis in human hepatic schistosomiasis ( Schistosoma mansoni). J Immunol 2003, 171:5596-5601.
88. Mwatha JK, Kimani G, Kamau T, et al. High levels of TNF, soluble TNF receptors, soluble ICAM-1 and IFNγ, but low levels of IL-5, are associated with hepatosplenic disease in human schistosomiasis mansoni. J Immunol 1998, 160:1992-1999.
89. Tsang VC, Wilkins PP Immunodiagnosis of schistosomiasis. Immunol Invest 1997, 26:175-188.
90. Essop AR, Posen JA, Hodkinson JH, et al. Tuberculosis hepatitis: a clinical review of 96 cases. Q J Med 1984, 53:465-477.
91. Bowry S, Chan CH, Weiss H, et al. Hepatic involvement in pulmonary tuberculosis. Histologic and functional characteristics. Am Rev Respir Dis 1970, 101:941-948.
92. Diaz ML, Herrera T, Lopez-Vidal Y, et al. Polymerase chain reaction for the detection of Mycobacterium tuberculosis DNA in tissue and assessment of its utility in the diagnosis of hepatic granulomas. J Lab Clin Med 1996, 127:359-363.
93. Maschek H, Georgii A, Schmidt RE, et al. Mycobacterium genavense. Autopsy findings in three patients. Am J Clin Pathol 1994, 101:95-99.
94. Farhi DC, Mason UG, Horsburgh CR Pathologic findings in disseminated Mycobacterium avium-intracellulare infection. A report of 11 cases. Am J Clin Pathol 1986, 85:67-72.
95. Patel KM Granulomatous hepatitis due to Mycobacterium scrofulaceum: report of a case. Gastroenterology 1981, 81:156-158.
96. Lamm DL, Mander Meijden ADPM, Morales A, et al. Incidence and treatment of complications of Bacillus Calmette-Guerin intravesical therapy in superficial bladder cancer. J Urol 1992, 147:596-600.
97. Bodurtha A, Kim YH, Laucius JF, et al. Hepatic granulomas and other hepatic lesions associated with BCG immunotherapy for cancer. Am J Clin Pathol 1974, 61:747-752.
98. Proctor DD, Chopra S, Rubenstein SC, et al. Mycobacteremia and granulomatous hepatitis following initial intravesical Bacillus Calmette-Guerin instillation for bladder carcinoma. Am J Gastroenterol 1993, 88:1112-1115.
99. McParland C, Cotton DJ, Gowda KS, et al. Miliary Mycobacterium bovis induced by the intravesical Bacillus Calmette-Guerin immunotherapy. Am Rev Respir Dis 1992, 146:1330-1333.
100. Maurin M, Raoult D. Q fever. Clin Microbiol Rev 1999, 12:518-553.
101. Q fever among slaughterhouse workers - California. MMWR Morb Mortal Wkly Rep 1986, 35:223-226. National Institutes of Health Consensus Development Conference Statement.
102. Hofmann CE, Heaton JW Q fever hepatitis: clinical manifestations and pathological findings. Gastroenterology 1982, 83:474-479.
103. Turck WPG, Howitt G, Turnberg LA, et al. Chronic Q fever. Q J Med 1976, 45:193-217.
104. Powell OW Liver involvement in 'Q' fever. Australas Ann Med 1961, 10:52-58.
105. Pellegrin M, Delsol G, Auvergnat JC, et al. Granulomatous hepatitis in Q fever. Hum Pathol 1980, 11:51-57.
106. Qizilbash AH The pathology of Q fever as seen on liver biopsy. Arch Pathol Lab Med 1983, 107:367-369.
107. Travis LB, Travis WD, Li CY, et al. Q fever. A clinicopathologic study of five cases. Arch Pathol Lab Med 1986, 110:1017-1020.
108. Westlake P, Price LM, Russell M, et al. The pathology of Q fever hepatitis. A case diagnosed by liver biopsy. J Clin Gastroenterol 1987, 9:357-363.
109. Atienza P, Ramond MJ, Degott C, et al. Chronic Q fever hepatitis complicated by extensive fibrosis. Gastroenterology 1988, 95:478-481.
110. Ruel M, Sevestre H, Henry-Biabaud E, et al. Fibrin ring granulomas in hepatitis A. Dig Dis Sci 1992, 37:1915-1917.
111. De Bayser L, Roblot P, Ramassamy A, et al. Hepatic fibrin-ring granulomas in giant cell arteritis. Gastroenterology 1993, 105:272-273.
112. Nenert M, Mavier P, Dubuc N, et al. Epstein-Barr virus infection and hepatic fibrin-ring granulomas. Hum Pathol 1988, 19:608-610.
113. Lobdell DH 'Ring' granulomas in cytomegalovirus hepatitis. Arch Pathol Lab Med 1987, 9:357-363.
114. Murphy E, Griffiths MR, Hunter JA, et al. Fibrin-ring granulomas: a non-specific reaction to liver injury?. Histopathology 1991, 19:91-93.
115. Moreno A, Marazuela M, Yebra M, et al. Hepatic fibrin-ring granulomas in visceral leishmaniasis. Gastroenterology 1988, 95:1123-1126.
116. Vanderstigel M, Zafrani ES, Lejonc JL, et al. Allopurinol hypersensitivity syndrome as a cause of hepatic fibrin-ring granulomas. Gastroenterology 1986, 90:188-190.
117. Hunt JG, Field PR, Murphy AM Immunoglobulin responses to Coxiella burnetii (Q fever): single-serum diagnosis of acute infection using an immunofluorescence technique. Infect Immun 1983, 39:977-981.
118. Peter O, Dupuis G, Burgdorfer W, et al. Evaluation of the complement fixation and indirect immunofluorescence tests in the early diagnosis of primary Q fever. Eur J Clin Microbiol 1985, 4:394-396.
119. Corbel MJ Brucellosis: an overview. Emerg Infect Dis 1997, 3:213-221.
120. Williams E. Brucellosis. Br Med J 1973, 2:791-793.
121. Williams E. Brucellosis in humans: its diagnosis and treatment. APMIS 1988, 3(Suppl):21-25.
122. Cervantes F, Bruguera M, Carbonell J, et al. Liver disease in brucellosis. A clinical and pathological study of 40 cases. Postgrad Med J 1982, 58:346-350.
123. Joint FAO/WHO expert committee on brucellosis. 6th Report. WHO Technical Report Series 1986; 740 56-58.
124. Ariza J, Gudiol F, Pallares R, et al. Treatment of human brucellosis with doxycycline plus rifampin or doxycycline plus streptomycin. Ann Intern Med 1992, 117:25-30.
125. Bass JW, Vincent JM, Person DA The expanding spectrum of Bartonella infections: II. Cat-scratch disease. Pediatr Infect Dis J 1997, 16:163-179.
126. Carithers HA Cat scratch disease. An overview based on a study of 1200 patients. Am J Dis Child 1985, 139:1124-1133.
127. Malatack JJ, Jaffe R Granulomatous hepatitis in three children due to cat-scratch disease without peripheral adenopathy. An unrecognized cause of fever of unknown origin. Am J Dis Child 1993, 147:949-953.
128. Dangman BC, Albanese BA, Kacica MA, et al. Cat scratch disease in two children presenting with fever of unknown origin: imaging features and association with a new causative agent, Rochalimaea henselae. Pediatrics 1995, 95:767-771.
129. Destuynder O, Vanlemmans P, Mboyo A, et al. Systemic cat scratch disease: hepatic and splenic involvement about 3 pediatric cases. Eur J Pediatr Surg 1995, 5:365-368.
130. Lamp LW, Gray GF, Scott MA The histologic spectrum of hepatic cat scratch disease. A series of six cases with confirmed Bartonella henselae infection. Am J Surg Pathol 1996, 20:1253-1259.
131. Rivera-Penera T, Nielsen K, Hall TR Radiological case of the month. Granulomatous hepatitis in cat-scratch disease. Arch Pediatr Adolesc Med 1998, 152:87-88.
132. Kahr A, Kerbl R, Gschwandtner K, et al. Visceral manifestation of cat scratch disease in children. A consequence of altered immunological state? Infection 2000, 28:778-784.
133. Margileth AM Antibiotic therapy for cat-scratch disease: clinical study of therapeutic outcome in 268 patients and a review of the literature. Pediatr Infect Dis J 1992, 11:474-478.
134. Simmons F, Feldman B, Gerety D. Granulomatous hepatitis in a patient receiving allopurinol. Gastroenterology 1972, 62:101-104.
135. Espiritu CR, Alalu J, Glueckauf LG, et al. Allopurinol-induced granulomatous hepatitis. Am J Dig Dis 1976, 21:804-806.
136. Swank LA, Chejfec G, Nemchausky BA Allopurinol-induced granulomatous hepatitis with cholangitis and a sarcoid-like reaction. Arch Intern Med 1978, 138:997-998.
137. Levander HG Granulomatous hepatitis in a patient receiving carbamazepine. Acta Med Scand 1980, 208:333-335.
138. Levy M, Goodman MW, Van Dyne BJ, et al. Granulomatous hepatitis secondary to carbamazepine. Ann Intern Med 1981, 95:64-65.
139. Mitchell MC, Boitnott JK, Arregui A, et al. Granulomatous hepatitis associated with carbamazepine therapy. Am J Med 1981, 71:733-735.
140. Soffer EE, Taylor RJ, Bertram PD, et al. Carbamazepine-induced liver injury. South Med J 1983, 76:681-683.
141. Rigberg LA, Robinson MJ, Espiritu CR Chlorpropamide-induced granulomas. A probable hypersensitivity reaction in liver and bone marrow. JAMA 1976, 235:409-410.
142. Ishak KG, Kirchner JP, Dhar JK Granulomas and cholestatic-hepatocellular injury associated with phenylbutazone. Report of two cases. Am J Dig Dis 1977, 22:611-617.
143. Chajek T, Lehrer B, Geltner D, et al. Quinidine-induced granulomatous hepatitis. Ann Intern Med 1974, 81:774-776.
144. Geltner D, Chajek T, Rubinger D, et al. Quinidine hypersensitivity and liver involvement. A survey of 32 patients. Gastroenterology 1976, 70:650-652.
145. Bramlet DA, Posalaky Z, Olson R Granulomatous hepatitis as a manifestation of quinidine hypersensitivity. Arch Intern Med 1980, 140:395-397.
146. Knobler H, Levij IS, Gavish D, et al. Quinidine-induced hepatitis. A common and reversible hypersensitivity reaction. Arch Intern Med 1986, 146:526-528.
147. Miller AC, Reid WM Methyldopa-induced granulomatous hepatitis. JAMA 1976, 235:2001-2002.
148. Jori GP, Peschile C Hydralazine disease associated with transient granulomas in the liver. A case report. Gastroenterology 1973, 64:1163-1167.
149. Sarachek NS, London RL, Matulewicz TJ Diltiazem and granulomatous hepatitis. Gastroenterology 1985, 88:1260-1262.
150. Toft E, Vyberg M, Therkelsen K. Diltiazem-induced granulomatous hepatitis. Histopathology 1991, 18:474-475.
151. Cook IF, Shilkin KB, Reed WD Phenytoin induced granulomatous hepatitis. Aust NZ J Med 1981, 11:539-541.
152. Colle I, Naegels S, Hoorens A, et al. Granulomatous hepatitis due to mebendazole. J Clin Gastroenterol 1999, 28:44-45.
153. Landas SK, Mitros FA, Furst DE, et al. Lipogranulomas and gold in the liver in rheumatoid arthritis. Am J Surg Pathol 1992, 16:171-174.
154. Katz B, Weetch M, Chopra S. Quinine-induced granulomatous hepatitis. Br Med J 1983, 286:264-265.
155. Mathur S, Dooley J, Scheuer PJ Quinine induced granulomatous hepatitis and vasculitis. Br Med J 1990, 300:613.
156. Shah IA, Brandt H Halothane-associated granulomatous hepatitis. Digestion 1983, 28:245-249.
157. Silvain C, Fort E, Levillain P, et al. Granulomatous hepatitis due to a combination of amoxicillin and clavulanic acid. Dig Dis Sci 1992, 37:150-152.
158. Kurumaya H, Kono N, Nakanuma Y, et al. Hepatic granulomata in long-term hemodialysis patients with hyperaluminumemia. Arch Pathol Lab Med 1989, 113:1132-1134.
159. Knobel B, Buyanowsky G, Dan M, et al. Pyrazinamide-induced granulomatous hepatitis. J. Clin Gastroenterol 1997, 24:264-266.
160. Lindgren A, Aldenborg F, Norkrans G, et al. Paracetamol-induced cholestatic and granulomatous liver injuries. J Intern Med 1997, 241:435-439.
161. Saw D, Pitman E, Maung M, et al. Granulomatous hepatitis associated with gliburide. Dig Dis Sci 1996, 41:322-325.
162. Braun M, Fraser GM, Kunin M, et al. Mesalamine-induced granulomatous hepatitis. Am J Gastroenterol 1999, 94:1973-1974.
163. Dhawan M, Agrawal R, Ravi J, et al. Rosiglitazone-induced granulomatous hepatitis. J Clin Gastroenterol 2002, 34:582-584.
164. Eliakim M, Eisenberg S, Levij IS, et al. Granulomatous hepatitis accompanying a self-limited febrile disease. Lancet 1968, 1:1348-1352.
165. Simon HB, Wolff SM Granulomatous hepatitis and prolonged fever of unknown origin: a study of 13 cases. Medicine 1973, 52:1-21.
166. Penchas S, Ligumski M, Eliakim M. Idiopathic granulomatous hepatitis with a prolonged course: effect of corticosteroid therapy. Digestion 1978, 17:46-55.
167. Shee CD, Creamer B Idiopathic granulomatous hepatitis and abdominal pain. Postgrad Med J 1980, 56:342-343.
168. Berlin CM, Boal DK, Zaino RJ, et al. Hepatic granulomata presenting with prolonged fever. Resolution with antiinflammatory treatment. Clin Pediatr 1990, 29:339-342.
169. Zoutman DE, Ralph Ed, Frei JV Granulomatous hepatitis and fever of unknown origin An 11-year experience of 23 cases with three years' follow-up. J Clin Gastroenterol 1991, 13:69-75.
170. Sartin JS, Walker RC Granulomatous hepatitis: a retrospective review of 88 cases at the Mayo Clinic. Mayo Clin Proc 1991, 66:914-918.
171. Knox TA, Kaplan MM, Gelfand JA, et al. Methotrexate treatment of idiopathic granulomatous hepatitis. Ann Intern Med 1995, 122:592-595.
172. Brincker H. Granulomatous lesions of unknown significance: the GLUS syndrome. Sarcoidosis and other granulomatous disorders 1994, 69-86. Marcel Dekker, New York. D.G. James (Ed.).
173. Kadin ME, Donaldson SS, Dorfman RF Granulomas in Hodgkin's disease. N Engl J Med 1970, 283:859-861.
174. Johnson LN, Iseri O, Knodell RG Caseating hepatic granulomas in Hodgkin's lymphoma. Gastroenterology 1990, 99:1837-1840.
175. Braylan RC, Long JC, Jaffe ES, et al. Malignant lymphoma obscured by concomitant extensive epithelioid granulomas: report of three cases with similar clinicopathologic features. Cancer 1977, 39:1146-1155.
176. Saito K, Nakanuma Y, Ogawa S, et al. Extensive hepatic granulomas associated with peripheral T cell lymphoma. Am J Gastroenterol 1991, 86:1243-1246.
177. Weissman JB, Neu HC Lepromatous leprosy masquerading as disseminated tuberculosis. Am J Med 1979, 67:113-116.
178. Karat ABA, Job CK, Rao PSS Liver in leprosy. Histologic and biochemical findings. Br Med J 1971, 1:307-310.
179. Chen TS, Drutz DJ, Whelan GE Hepatic granulomas in leprosy. Their relation to bacteremia. Arch Pathol Lab Med 1976, 100:182-185.
180. De Vega T, Echevarria S, Crespo J, et al. Acute hepatitis by Listeria monocytogenes in an HIV patient with chronic HBV hepatitis. J Clin Gastroenterol 1992, 15:251-255.
181. Henderson JR, Ramsey CA Miliary granulomata in a fatal adult case of listerial meningitis. Postgrad Med J 1967, 43:794-796.
182. Jones JM Granulomatous hepatitis due to Candida albicans in patients with acute leukemia. Ann Intern Med 1981, 94:475-477.
183. Lamps LW, Molina CP, West AB, et al. The pathologic spectrum of gastrointestinal and hepatic histoplasmosis. Am J Clin Pathol 2000, 113:64-72.
184. Howard PF, Swith JW Diagnosis of disseminated coccidiomycosis by liver biopsy. Arch Intern Med 1983, 143:1335-1338.
185. Lefton HB, Farmer RG, Buchwald R, et al. Cryptococcal hepatitis mimicking primary sclerosing cholangitis. A case report. Gastroenterology 1974, 67:511-515.
186. Teixeira F, Gayotto LC, De Brito T. Morphological patterns of the liver in South American blastomycosis. Histopathology 1978, 2:231-237.
187. Weitberg AB, Alper JC, Diamond I, et al. Acute granulomatous hepatitis in the course of acquired toxoplasmosis. N Engl J Med 1979, 300:1093-1096.
188. Clarke J, Craig RM, Saffro R, et al. Cytomegalovirus granulomatous hepatitis. Am J Med 1979, 66:264-269.
189. Litwack KD, Bohan A, Silverman L Granulomatous liver disease and giant cell arteritis. Case report and literature review. J Rheumatol 1977, 4:307-312.
190. Malatjalian DA, Graham CH Liver adenoma with granulomas. The appearance of granulomas in oral contraceptive-related hepatocellular adenoma and in the surrounding nontumorous liver. Arch Pathol Lab Med 1982, 106:244-246.